BERGENBIO ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.18 NOK | -2.93% |
|
+6.30% | -56.18% |
| May. 29 | BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 29 | Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024 |
Chart calendar BerGenBio ASA
211b5abb8929fa824c43aad.1p0_Oh6OZvIZ15N6l_gdzxb_qXinPdZf6JT9n7faMaw.5sJRdWzWA4BOgqdKoLcw_UbP2hXvBYA50PaXxc6fZZ2C6lNNTe8to2vvpw~5ad85259150bb4383f94226f64a9578b
Upcoming events on BerGenBio ASA
Past events on BerGenBio ASA
| 2024-05-29 04:00 am | Q1 2024 Earnings Call |
| 2024-05-29 01:25 am | Q1 2024 Earnings Release |
| 2024-05-22 | Annual General Meeting |
| 2024-02-14 04:00 am | Q4 2023 Earnings Call |
| 2024-02-14 01:00 am | Q4 2023 Earnings Release |
| 2023-11-14 04:00 am | Q3 2023 Earnings Call |
| 2023-11-14 01:20 am | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Board Number: 598 |
| 2023-10-22 | European Society for Medical Oncology Congress - Poster Number: 1440P |
| 2023-10-21 09:50 am | European Society for Medical Oncology Congress |
| 2023-08-23 04:45 am | Q2 2023 Earnings Call |
| 2023-08-23 01:00 am | Q2 2023 Earnings Release |
| 2023-06-22 01:00 am | Q1 2023 Earnings Release |
| 2023-06-04 | American Society of Clinical Oncology Meeting |
| 2023-06-02 05:00 am | Arctic Securities and Carnegie Conference |
| 2023-05-22 04:00 pm | Annual General Meeting |
| 2023-05-15 04:00 am | Business Update Call |
| 2023-02-16 04:00 am | FY 2022 Earnings Call |
| 2023-02-16 01:00 am | FY 2022 Earnings Release |
| 2022-11-15 04:00 am | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 8,90 8,70 2.3% | 0,60 0,00 - | 0,80 0,00 - | 0,39 0,00 - | 0,35 0,00 - | 0,10 |
|
EBITDA Million NOK | Released Forecast Spread | -204 -201 -1.49% | -260 -258 -0.97% | -313 -320 2.06% | -305 -317 3.86% | -192 -221 13.41% | -197 |
|
EBIT Million NOK | Released Forecast Spread | -204 -200 -2.2% | -261 -259 -0.96% | -315 -321 2.15% | -306 -314 2.56% | -192 -222 13.51% | -197 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -199 -196 -1.8% | -257 -250 -2.78% | -309 -314 1.35% | -302 -309 2.35% | -190 -221 13.71% | -195 |
|
Net income Million NOK | Released Forecast Spread | -199 -196 -1.8% | -257 -250 -2.78% | -309 -314 1.35% | -302 -309 2.35% | -190 -221 13.71% | -195 |
|
EPS NOK | Released Forecast Spread | -343 -337 -1.78% | -343 -342 -0.41% | -352 -357 1.32% | -341 -349 2.38% | -13,0 -13,4 2.82% | -229 |
| Announcement Date | 11/02/20 | 10/02/21 | 16/02/22 | 16/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,39 0,00 - | 0,00 0,00 - | 0,35 0,00 - | 0,17 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | ||
|
EBITDA Million NOK | Released Forecast Spread | -78,2 -68,8 -13.82% | -87,9 -73,8 -19.22% | -62,3 -83,8 25.63% | -76,3 -82,0 6.93% | -72,4 -100 27.58% | -28,0 -57,6 51.42% | -43,4 -33,4 -30.07% | -39,7 -46,2 14.16% | -51,0 | -90,7 | -52,9 | -65,9 | ||||
|
EBIT Million NOK | Released Forecast Spread | -176 -168 -4.85% | -78,6 -70,0 -12.18% | -88,2 -75,0 -17.53% | -167 -155 -7.89% | -62,4 -84,1 25.75% | -76,4 -89,1 14.23% | -72,4 -100 27.81% | -43,5 -33,4 -30.37% | ||||||||
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -116 -102 -13.23% | -170 -164 -3.78% | -81,1 -68,9 -17.64% | -84,1 -73,9 -13.73% | -165 -156 -5.79% | -59,8 -82,8 27.8% | -77,2 -81,7 5.48% | -72,0 -99,8 27.88% | -27,9 -58,3 52.09% | -41,6 -33,5 -24.28% | -36,1 -45,1 19.92% | -48,7 | -84,8 | -51,4 | -67,0 | |
|
Net income Million NOK | Released Forecast Spread | -116 -102 -13.23% | -170 -164 -3.78% | -81,1 -68,9 -17.64% | -84,1 -73,9 -13.74% | -165 -156 -5.79% | -59,8 -82,8 27.8% | -77,2 -81,7 5.48% | -72,0 -99,8 27.88% | -48,8 | -27,9 -58,3 52.09% | -41,6 -33,5 -24.28% | -36,1 -45,1 19.92% | -48,7 | -84,8 | -51,4 | -67,0 |
|
EPS NOK | Released Forecast Spread | -159 -133 -19.55% | -194 -186 -4.3% | -92,0 -78,0 -17.95% | -95,0 -83,0 -14.46% | -186 -175 -6.29% | -87,0 -85,0 -2.35% | -15,0 | -1,00 -2,00 50% | -2,00 -1,00 -100% | -1,00 -2,00 50% | -1,25 | -2,57 | -1,31 | -1,69 | ||
| Announcement Date | 17/08/20 | 17/08/21 | 24/05/22 | 23/08/22 | 23/08/22 | 15/11/22 | 16/02/23 | 22/06/23 | 23/08/23 | 14/11/23 | 14/02/24 | 29/05/24 | - | - | - | - |
More events
Past sector events for BerGenBio ASA
| 2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BGBIO Stock
- Calendar BerGenBio ASA
